The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Krueger Christopher W since 2009.
This trader's CIK number is 1394208.
At the time of last reporting, Krueger Christopher W was the CHIEF BUSINESS OFFICER of Ventyx Biosciences, Inc.. (stock ticker symbol VTYX).
Also see all insider trading activities at Ventyx Biosciences, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2010 | RDEA | 0 | $0 | 22,145 | $461,674 | 21,000 | $109,200 |
2009 | RDEA | 0 | $0 | 44,561 | $703,783 | 40,000 | $207,999 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | VTYX | 0 | $0 | 1,651 | $8,922 | 4,531 | $0 |
2023 | VTYX | 0 | $0 | 110,293 | $3,639,995 | 108,926 | $654,904 |
2022 | VTYX | 0 | $0 | 3,654 | $115,517 | 349,202 | $67,744 |
1. Intrabiotics Pharmaceuticals Inc /de (RDEA)
2. Ventyx Biosciences, Inc. (VTYX)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2010-07-23 | RDEA | Option Ex | 3,000 | 5.20 | 15,600 |
2010-07-23 | RDEA | Sale | 3,000 | 18.54 | 55,611 |
2010-06-23 | RDEA | Sale | 3,000 | 21.93 | 65,799 |
2010-06-23 | RDEA | Option Ex | 3,000 | 5.20 | 15,600 |
2010-05-24 | RDEA | Option Ex | 3,000 | 5.20 | 15,600 |
2010-05-24 | RDEA | Sale | 3,000 | 22.97 | 68,907 |
2010-05-17 | RDEA | Sale | 1,145 | 23.19 | 26,554 |
2010-04-23 | RDEA | Option Ex | 3,000 | 5.20 | 15,600 |
2010-04-23 | RDEA | Sale | 3,000 | 26.24 | 78,717 |
2010-03-23 | RDEA | Option Ex | 9,000 | 5.20 | 46,800 |
2010-03-23 | RDEA | Sale | 9,000 | 18.45 | 166,086 |
2009-12-23 | RDEA | Option Ex | 6,000 | 5.20 | 31,200 |
2009-12-23 | RDEA | Sale | 6,000 | 15.11 | 90,684 |
2009-10-23 | RDEA | Option Ex | 3,000 | 5.20 | 15,600 |
2009-10-23 | RDEA | Sale | 3,000 | 15.25 | 45,762 |
2009-09-23 | RDEA | Option Ex | 3,000 | 5.20 | 15,600 |
2009-09-23 | RDEA | Sale | 3,000 | 19.08 | 57,234 |
2009-08-24 | RDEA | Sale | 5,061 | 19.00 | 96,179 |
2009-08-24 | RDEA | Option Ex | 3,000 | 5.20 | 15,600 |
2009-05-19 | RDEA | Option Ex | 2,502 | 5.20 | 13,010 |
2009-05-20 | RDEA | Option Ex | 22,498 | 5.20 | 116,989 |
2009-05-19 | RDEA | Sale | 2,502 | 15.27 | 38,205 |
2009-05-20 | RDEA | Sale | 24,998 | 15.03 | 375,719 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-04-02 | VTYX | Sale | 1,651 | 5.40 | 8,922 |
2024-03-28 | VTYX | Option Ex | 4,531 | .00 | 0 |
2023-12-20 | VTYX | Sale | 5,293 | 2.12 | 11,210 |
2023-12-17 | VTYX | Option Ex | 10,479 | .00 | 0 |
2023-10-03 | VTYX | Sale | 15,000 | 30.31 | 454,695 |
2023-10-03 | VTYX | Option Ex | 15,000 | 8.04 | 120,599 |
2023-09-05 | VTYX | Option Ex | 15,000 | 8.04 | 120,599 |
2023-09-05 | VTYX | Sale | 15,000 | 33.21 | 498,195 |
2023-08-03 | VTYX | Option Ex | 15,000 | 8.04 | 120,599 |
2023-08-03 | VTYX | Sale | 15,000 | 35.73 | 535,905 |
2023-07-03 | VTYX | Sale | 15,000 | 36.75 | 551,235 |
2023-07-03 | VTYX | Option Ex | 15,000 | 4.12 | 61,800 |
2023-06-05 | VTYX | Option Ex | 15,000 | 4.12 | 61,800 |
2023-06-05 | VTYX | Sale | 15,000 | 34.48 | 517,215 |
2023-05-03 | VTYX | Option Ex | 15,000 | 8.04 | 120,599 |
2023-05-03 | VTYX | Sale | 15,000 | 38.56 | 578,370 |
2022-04-03 | VTYX | Sale | 15,000 | 32.88 | 493,170 |
2022-04-03 | VTYX | Option Ex | 8,447 | 5.79 | 48,908 |
2022-12-22 | VTYX | Sale | 3,654 | 31.61 | 115,517 |
2022-12-17 | VTYX | Option Ex | 10,480 | .00 | 0 |
2022-08-23 | VTYX | Option Ex | 169,361 | .20 | 33,872 |
2022-08-23 | VTYX | Option Ex | 169,361 | .20 | 33,872 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Krueger Christopher W (CHIEF BUSINESS OFFICER of Ventyx Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.